Novel nile blue analogue stains yeast vacuolar membrane, endoplasmic reticulum, and lipid droplets, inducing cell death through vacuole membrane permeabilization

• Autor(a) principal: Ferreira, João Carlos Canossa
• Data de Publicação: 2021
• Outros Autores: Lopes, Carla, Preto, Ana, Gonçalves, Maria Sameiro Torres, Sousa, Maria João
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: https://hdl.handle.net/1822/76334
• topic: benzo[a]phenoxazine derivative; Nile Blue analogue; cell death mechanism; vacuole/lysosome membrane permeabilization; yeast as a eukaryotic cell model; vacuole; lysosome membrane permeabilization; Ciências Naturais::Ciências Biológicas; Science & Technology

Phenoxazine derivatives such as Nile Blue analogues are assumed to be increasingly relevant in cell biology due to their fluorescence staining capabilities and antifungal and anticancer activities. However, the mechanisms underlying their effects remain poorly elucidated. Using <i>S. cerevisiae</i> as a eukaryotic model, we found that BaP1, a novel 5- and 9-<i>N</i>-substituted benzo[<i>a</i>]phenoxazine synthesized in our laboratory, when used in low concentrations, accumulates and stains the vacuolar membrane and the endoplasmic reticulum. In contrast, at higher concentrations, BaP1 stains lipid droplets and induces a regulated cell death process mediated by vacuolar membrane permeabilization. BaP1 also induced mitochondrial fragmentation and depolarization but did not lead to ROS accumulation, changes in intracellular Ca²⁺, or loss of plasma membrane integrity. Additionally, our results show that the cell death process is dependent on the vacuolar protease Pep4p and that the vacuole permeabilization results in its translocation from the vacuole to the cytosol. In addition, although nucleic acids are commonly described as targets of benzo[<i>a</i>]phenoxazines, we did not find any alterations at the DNA level. Our observations highlight BaP1 as a promising molecule for pharmacological application, using vacuole membrane permeabilization as a targeted approach.